DNA Operating Cash Flow Growth
Ginkgo Bioworks Holdings Inc Class · Operating Cash Flow Growth
DNA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported28.38%period ending
DNA TTM Cash from Operations YoY % (-86.86% → 28.38%)
Year-over-year change
High-resolution chart · PNG
DNA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 28.3824% | |
| 41.0233% | |
| 46.4746% | |
| 50.4999% | |
| 22.0699% | |
| 4.1904% | |
| -8.1506% | |
| 2.1096% | |
| -2.6622% | |
| 8.892% | |
| -17.1698% | |
| -9.2565% | |
| -2.4658% | |
| -43.1323% | |
| 0.6383% | |
| -112.1775% | |
| -72.9611% | |
| -41.0356% | |
| -86.8645% |